RESUMEN
DNA sequence information underpins genetic research, enabling discoveries of important biological or medical benefit. Sequencing projects have traditionally used long (400-800 base pair) reads, but the existence of reference sequences for the human and many other genomes makes it possible to develop new, fast approaches to re-sequencing, whereby shorter reads are compared to a reference to identify intraspecies genetic variation. Here we report an approach that generates several billion bases of accurate nucleotide sequence per experiment at low cost. Single molecules of DNA are attached to a flat surface, amplified in situ and used as templates for synthetic sequencing with fluorescent reversible terminator deoxyribonucleotides. Images of the surface are analysed to generate high-quality sequence. We demonstrate application of this approach to human genome sequencing on flow-sorted X chromosomes and then scale the approach to determine the genome sequence of a male Yoruba from Ibadan, Nigeria. We build an accurate consensus sequence from >30x average depth of paired 35-base reads. We characterize four million single-nucleotide polymorphisms and four hundred thousand structural variants, many of which were previously unknown. Our approach is effective for accurate, rapid and economical whole-genome re-sequencing and many other biomedical applications.
Asunto(s)
Genoma Humano/genética , Genómica/métodos , Análisis de Secuencia de ADN/métodos , Cromosomas Humanos X/genética , Secuencia de Consenso/genética , Genómica/economía , Genotipo , Humanos , Masculino , Nigeria , Polimorfismo de Nucleótido Simple/genética , Sensibilidad y Especificidad , Análisis de Secuencia de ADN/economíaRESUMEN
Cholera toxin (CT) travels from the plasma membrane of intestinal cells to the endoplasmic reticulum (ER) where a portion of the A-subunit, the A1 chain, crosses the membrane into the cytosol to cause disease. A related toxin, LTIIb, binds to intestinal cells but does not cause toxicity. Here, we show that the B-subunit of CT serves as a carrier for the A-subunit to the ER where disassembly occurs. The B-subunit binds to gangliosides in lipid rafts and travels with the ganglioside to the ER. In many cells, LTIIb follows a similar pathway, but in human intestinal cells it binds to a ganglioside that fails to associate with lipid rafts and it is sorted away from the retrograde pathway to the ER. Our results explain why LTIIb does not cause disease in humans and suggest that gangliosides with high affinity for lipid rafts may provide a general vehicle for the transport of toxins to the ER.
Asunto(s)
Toxinas Bacterianas/metabolismo , Toxina del Cólera/metabolismo , Retículo Endoplásmico/metabolismo , Células Epiteliales/metabolismo , Gangliósidos/metabolismo , Microdominios de Membrana/metabolismo , Animales , Transporte Biológico/fisiología , Células Cultivadas , Clonación Molecular , Endocitosis , Aparato de Golgi , Humanos , Mucosa Intestinal/metabolismo , Unión Proteica , Subunidades de Proteína/metabolismoRESUMEN
Cholera toxin (CT) follows a glycolipid-dependent entry pathway from the plasma membrane through the trans-Golgi network (TGN) to the endoplasmic reticulum (ER) where it is retro-translocated into the cytosol to induce toxicity. Whether access to the Golgi apparatus is necessary for transport to the ER is not known. Exo2 is a small chemical that rapidly blocks anterograde traffic from the ER to the Golgi and selectively disrupts the Golgi apparatus but not the TGN. Here we use Exo2 to determine the role of the Golgi apparatus in CT trafficking. We find that under the condition of complete Golgi ablation by Exo2, CT reaches the TGN and moves efficiently into the ER without loss in toxicity. We propose that even in the absence of Exo2 the glycolipid pathway that carries the toxin from plasma membrane into the ER bypasses the Golgi apparatus entirely.
Asunto(s)
Benzaldehídos/farmacología , Membrana Celular/fisiología , Toxina del Cólera/metabolismo , Retículo Endoplásmico/fisiología , Pirimidinas/farmacología , Red trans-Golgi/fisiología , Animales , Línea Celular , Membrana Celular/efectos de los fármacos , Toxina del Cólera/análisis , Colforsina/farmacología , Conductividad Eléctrica , Glicoproteínas/análisis , Aparato de Golgi/química , Aparato de Golgi/efectos de los fármacos , Aparato de Golgi/fisiología , Transporte de Proteínas/efectos de los fármacos , Transporte de Proteínas/fisiología , Receptores de Péptidos/análisis , Red trans-Golgi/química , Red trans-Golgi/efectos de los fármacosRESUMEN
Cholera toxin travels from the cell surface of affected mammalian cells to the endoplasmic reticulum (ER), where the A1 chain is released and retro-translocated across the ER membrane into the cytosol. We have tested whether, as in other cases, retro-translocation requires poly-ubiquitination. We show that an A1 chain mutant that lacks lysines and has a blocked N-terminus, and therefore cannot be ubiquitinated, remains active in vivo. The A1 chain is not degraded in the cytosol, as demonstrated by the fact that proteasome inhibitors do not stimulate its activity. When additional lysines are introduced into the A1 chain, moderate degradation by the proteasome is observed. The unfolded A1 chain rapidly refolds in vitro. These results show that poly-ubiquitination is not required for retro-translocation of all proteins across the ER membrane and indicate that the reason why the toxin escapes degradation in the cytosol may be both its paucity of lysines and its rapid refolding.